Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy

被引：81

作者：

Egan, Amy ^{[1
]}

Colman, Eric ^{[1
]}

机构：

[1] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 04期

关键词：

D O I：

10.1056/NEJMp1106689

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：285 / 287

页数：3

共 5 条

[1] Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial [J].

Armitage, Jane ;

Bowman, Louise ;

Wallendszus, Karl ;

Bulbulia, Richard ;

Rahimi, Kazem ;

Haynes, Richard ;

Parish, Sarah ;

Peto, Richard ;

Collins, Rory ;

Meade, T. ;

Sleight, P. ;

Collins, R. ;

Armitage, J. ;

Bowman, L. ;

Parish, S. ;

Peto, R. ;

Barton, J. ;

Bray, C. ;

Wincott, E. ;

Dayanandan, R. ;

Clarke, R. ;

Graham, I. ;

Simpson, D. ;

Warlow, C. ;

Wilken, D. ;

Tobert, J. ;

Mushner, T. ;

Doll, R. ;

Wilhelmsen, L. ;

Fox, K. ;

Hill, C. ;

Sandercock, P. ;

Webster, J. ;

Henderson, J. ;

Nixon, A. ;

Lackie, S. ;

Thompson, J. ;

Brown, M. ;

Blackwood, S. ;

Morgan, M. ;

Rhoden, W. ;

Saeed, B. ;

Houghton, M. ;

Nicholson, A. ;

Simpson, C. ;

Hoburn, B. ;

Cooper, I. ;

Gallivan, A. ;

Pickerell, E. ;

Hancock, J. .

LANCET, 2010, 376 (9753) :1658-1669

[2]

Baigent C, 2008, LANCET, V371, P2084

[3] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[4]

Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936

[5]

Smith M., 2009, Drug class review: HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin: Final report update 5

← 1 →